An engineered PD-1 receptor-based CAR that binds anti-PD-1 antibodies but not PD-L1 to enhance T-cell functionality

Molecular Therapy: Oncology · Elsevier

Аннотация

Publication date: Available online 1 October 2026 Source: Molecular Therapy Oncology Author(s): Jordy Schaukens, Lorenzo Franceschini, Latoya Stevens, Fien Meeus, Giada Bertazzon, Arthur Esprit, Dorien Autaers, Yannick De Vlaeminck, Karine Breckpot, Bart Neyns, Xenia Geeraerts, Sandra Tuyaerts

Читать у издателя →

Похожие статьи